Breast cancer is the most common malignancy in Nigeria, it accounts for 22.7 percent of all new cancer cases among women, according to reports. To bridge the care gap while improving access to quality healthcare for breast cancer patients in Nigeria, Pfizer has installed a Telemedicine Centre at the
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp